Pharmena S.A. Working Capital to Net Assets Ratio
Pharmena S.A. working capital to net assets ratio. Pharmena S.A. (PHR) has a Working Capital to Net Assets ratio of 85.4% as of September 2025. Working capital of zł9.00 Million (current assets of zł9.72 Million minus current liabilities of zł719.00K) is measured against net assets of zł10.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Pharmena S.A. to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pharmena S.A. (2008–2024)
Working capital to net assets ratio of Pharmena S.A. from 2008 to 2024. This chart shows how Pharmena S.A.'s Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 85.4%, reflecting working capital of zł9.00 Million against net assets of zł10.54 Million PLN. See defensive interval ratio of Pharmena S.A. to measure how many days the company can operate on defensive assets alone.
Pharmena S.A. Working Capital to Net Assets Ratio by Year (2008–2024)
Pharmena S.A. working capital to net assets ratio by year from 2008 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Pharmena S.A. from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PHR asset base.
| Year | WC/NA Ratio | Working Capital (PLN) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 88.3% | zł10.96 Million | zł12.42 Million | zł11.88 Million | zł915.00K | ▼ -8.7 pp |
| 2023 | 97.0% | zł21.56 Million | zł22.23 Million | zł23.33 Million | zł1.77 Million | ▼ -6.1 pp |
| 2022 | 103.1% | zł-7.00 Million | zł-6.79 Million | zł9.97 Million | zł16.97 Million | ▲ +37.1 pp |
| 2021 | 66.0% | zł-3.38 Million | zł-5.12 Million | zł8.20 Million | zł11.58 Million | ▼ -759.0 pp |
| 2020 | 825.0% | zł-2.87 Million | zł-348.00K | zł8.26 Million | zł11.13 Million | ▲ +790.1 pp |
| 2019 | 34.9% | zł1.74 Million | zł5.00 Million | zł8.25 Million | zł6.51 Million | ▲ +41.2 pp |
| 2018 | -6.3% | zł-122.00K | zł1.94 Million | zł4.68 Million | zł4.81 Million | ▼ -58.6 pp |
| 2017 | 52.3% | zł1.86 Million | zł3.56 Million | zł9.27 Million | zł7.41 Million | ▼ -17.7 pp |
| 2016 | 70.1% | zł4.16 Million | zł5.94 Million | zł12.33 Million | zł8.16 Million | ▼ -9.6 pp |
| 2015 | 79.7% | zł6.91 Million | zł8.67 Million | zł13.23 Million | zł6.33 Million | ▼ -3.0 pp |
| 2014 | 82.7% | zł10.82 Million | zł13.08 Million | zł14.27 Million | zł3.45 Million | ▼ -2.8 pp |
| 2013 | 85.5% | zł15.44 Million | zł18.05 Million | zł17.84 Million | zł2.40 Million | ▲ +20.7 pp |
| 2012 | 64.8% | zł5.82 Million | zł8.98 Million | zł8.26 Million | zł2.44 Million | ▲ +28.6 pp |
| 2011 | 36.3% | zł5.97 Million | zł16.45 Million | zł7.37 Million | zł1.41 Million | ▼ -7.3 pp |
| 2010 | 43.6% | zł6.93 Million | zł15.91 Million | zł7.64 Million | zł708.32K | ▼ -26.5 pp |
| 2009 | 70.1% | zł11.32 Million | zł16.16 Million | zł12.15 Million | zł824.55K | ▼ -14.2 pp |
| 2008 | 84.2% | zł13.29 Million | zł15.78 Million | zł13.89 Million | zł599.36K | — |